John Mark Lucas
Keine laufenden Positionen mehr
Karriereverlauf von John Mark Lucas
Ehemalige bekannte Positionen von John Mark Lucas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Direktor/Vorstandsmitglied | 23.04.2021 | 02.12.2022 |
Vorstandsvorsitzender | 01.01.2021 | 02.12.2022 | |
Corporate Officer/Principal | 01.08.2018 | 01.01.2021 | |
VENTURE LIFE GROUP PLC | Direktor/Vorstandsmitglied | - | 05.08.2014 |
Corporate Officer/Principal | - | 05.08.2014 | |
ILIKA PLC | Corporate Officer/Principal | - | - |
Boehringer Ingelheim Pharma GmbH & Co., KG
Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach. | Corporate Officer/Principal | - | - |
Genset Corp.
Genset Corp. Pharmaceuticals: MajorHealth Technology Founded in 1992, Genset Corp. is a pharmaceutical company that manufactures and markets pharmaceuticals. The company is based in San Diego, CA and is a part of Merck KGaA. | Corporate Officer/Principal | - | - |
Cizzle Biotechnology Ltd.
Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom. | Präsident | 13.12.2010 | - |
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Corporate Officer/Principal | - | - |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - | - |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von John Mark Lucas
George Washington University | Graduate Degree |
The Ohio State University | Doctorate Degree |
The Ohio University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Vereinigtes Königreich | 6 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 9 |
Graduate Degree | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
SILENCE THERAPEUTICS PLC | Commercial Services |
VENTURE LIFE GROUP PLC | Health Technology |
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Health Technology |
ILIKA PLC | Producer Manufacturing |
Private Unternehmen | 6 |
---|---|
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
Cizzle Biotechnology Ltd.
Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom. | Health Technology |
Genset Corp.
Genset Corp. Pharmaceuticals: MajorHealth Technology Founded in 1992, Genset Corp. is a pharmaceutical company that manufactures and markets pharmaceuticals. The company is based in San Diego, CA and is a part of Merck KGaA. | Health Technology |
Boehringer Ingelheim Pharma GmbH & Co., KG
Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach. | Health Technology |
- Börse
- Insiders
- John Mark Lucas
- Erfahrung